These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 481115)

  • 41. [Action of hallucinogens on electroencephalograms].
    Oughourlian JM; Rougeul A; Verdeaux J
    Therapie; 1971; 26(5):953-68. PubMed ID: 5160349
    [No Abstract]   [Full Text] [Related]  

  • 42. PSYCHODYNAMIC and therapeutic aspects of mescaline and lysergic acid diethylamide: round table.
    J Nerv Ment Dis; 1957; 125(3):423-4. PubMed ID: 13481746
    [No Abstract]   [Full Text] [Related]  

  • 43. Studies on the concurrent behavioral and neurochemical effects of psychoactive drugs using the push-pull cannula.
    Tilson HA; Sparber SB
    J Pharmacol Exp Ther; 1972 Jun; 181(3):387-98. PubMed ID: 5033008
    [No Abstract]   [Full Text] [Related]  

  • 44. EEG effects of hallucinogens and cannabinoids using sleep-waking behavior as baseline.
    Fairchild MD; Jenden DJ; Mickey MR; Yale C
    Pharmacol Biochem Behav; 1980 Jan; 12(1):99-105. PubMed ID: 6102770
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prolonged survival of the isolated retina induced by drugs; strychnine, mescaline, d-lysergic acid diethylamide (LSD), and atropine.
    APTER JT
    AMA Arch Ophthalmol; 1958 May; 59(5):722-30. PubMed ID: 13519998
    [No Abstract]   [Full Text] [Related]  

  • 46. Reticular multiple unit activity during a progression of states induced by CNS excitants. 3.
    Winters WD; Mori K; Wallach MB; Marcus RJ; Spooner CE
    Electroencephalogr Clin Neurophysiol; 1969 Nov; 27(5):514-22. PubMed ID: 4187037
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparative effects of hallucinogenic drugs on behavior of the cat.
    Jacobs BL; Trulson ME; Stark AD; Christoph GR
    Commun Psychopharmacol; 1977; 1(3):243-54. PubMed ID: 272265
    [No Abstract]   [Full Text] [Related]  

  • 48. [Influence of mescaline and of lysergic acid diethylamide (LSD-25) on the development of primary and secondary conditioned avoidance reflexes in rats].
    MAFFII G
    Farmaco Sci; 1959 Jul; 14():503-15. PubMed ID: 13853753
    [No Abstract]   [Full Text] [Related]  

  • 49. [Change in complex forms of conditioned reflexes caused by the application of lysergic acid diethylamide (LSD) and mescaline to the cortical ends of the auditory and visual analyzers].
    Alekseeva LA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1969; 19(2):279-85. PubMed ID: 5404353
    [No Abstract]   [Full Text] [Related]  

  • 50. Neurological aspects of hallucinogenic drugs.
    Logan WJ
    Adv Neurol; 1975; 13():47-78. PubMed ID: 814800
    [No Abstract]   [Full Text] [Related]  

  • 51. Psychedelic drugs and creativity.
    Krippner S
    J Psychoactive Drugs; 1985; 17(4):235-45. PubMed ID: 4087078
    [No Abstract]   [Full Text] [Related]  

  • 52. Facilitation of avoidance behaviour by LSD-25 and mescaline in hamsters.
    Sansone M; Castellano C; Messeri P
    Pharmacol Res Commun; 1974 Aug; 6(4):369-76. PubMed ID: 4438404
    [No Abstract]   [Full Text] [Related]  

  • 53. Vasoconstriction produced by hallucinogens on isolated human and sheep umbilical vasculature.
    Dyer DC; Gant DW
    J Pharmacol Exp Ther; 1973 Feb; 184(2):366-75. PubMed ID: 4347258
    [No Abstract]   [Full Text] [Related]  

  • 54. Cross tolerance or tachyphylaxis among various psychotomimetic agents on cats.
    Wallach MB; Hine B; Gershon S
    Eur J Pharmacol; 1974 Nov; 29(1):89-92. PubMed ID: 4435048
    [No Abstract]   [Full Text] [Related]  

  • 55. LDS-25 as a discriminative stimulus for response selection by pigeons.
    Järbe TU
    Pharmacol Biochem Behav; 1980 Oct; 13(4):549-54. PubMed ID: 6107936
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Theoretical studies on the conformations of psilocin and mescaline.
    Kang S; Johnson CL; Green JP
    Mol Pharmacol; 1973 Sep; 9(5):640-8. PubMed ID: 4788158
    [No Abstract]   [Full Text] [Related]  

  • 57. The pharmacology of hallucinogens.
    Brawley P; Duffield JC
    Pharmacol Rev; 1972 Mar; 24(1):31-66. PubMed ID: 4626282
    [No Abstract]   [Full Text] [Related]  

  • 58. Hallucinogens potentiate responses to serotonin and norepinephrine in the facial motor nucleus.
    McCall RB; Aghajanian GK
    Life Sci; 1980 Apr; 26(14):1149-56. PubMed ID: 7392793
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of mescaline and lysergic acid diethylamide on flicker discrimination in the rat.
    Schechter MD; Winter JC
    J Pharmacol Exp Ther; 1971 May; 177(2):461-7. PubMed ID: 5568801
    [No Abstract]   [Full Text] [Related]  

  • 60. [Halluciogenic substances and sleep mechanisms].
    Rougeul A; Verdeaux J
    Rev Can Biol; 1972; 31():Suppl:49-58. PubMed ID: 4538208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.